Lasa Supergenerics (NSE:LASA) Total Liabilities: ₹166.5 Mil (As of Mar. 2026)


NSE:LASA Lasa Supergenerics Ltd NSE:LASA
47 GF Score
Price ₹7.30
GF Value ₹4.33
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Total Liabilities?

Lasa Supergenerics NSE:LASA -0.95% 47 Total Liabilities is ₹166.5 Mil as of Mar. 2026. GuruFocus rates NSE:LASA with a GF Score™ of 47/100 and a GF Value™ of ₹4.33 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Lasa Supergenerics's Total Liabilities for the quarter that ended in Mar. 2026 was ₹166.5 Mil.

Lasa Supergenerics's quarterly Total Liabilities declined from Sep. 2025 (₹152.61 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹166.49 Mil).

Lasa Supergenerics's annual Total Liabilities declined from Mar. 2024 (₹541.92 Mil) to Mar. 2025 (₹178.19 Mil) and declined from Mar. 2025 (₹178.19 Mil) to Mar. 2026 (₹166.49 Mil).

Lasa Supergenerics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lasa Supergenerics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics Total Liabilities Chart

Lasa Supergenerics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 512.87 455.69 541.92 178.19 166.49

Lasa Supergenerics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 178.19 0.00 152.61 0.00 166.49
NSE:LASA
47GF Score
Lasa Supergenerics Ltd NSE:LASA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lasa Supergenerics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lasa Supergenerics's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=167.724+(0+-2.953
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.718+0)
=166.5

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=662.718-496.229
=166.5

Lasa Supergenerics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=167.724+(0+-2.953
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.718+0)
=166.5

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=662.718-496.229
=166.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹166.5 Mil mean?
Lasa Supergenerics (NSE:LASA) has a Total Liabilities of ₹166.5 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lasa Supergenerics and its competitors.
Is Lasa Supergenerics' Total Liabilities too high?
Lasa Supergenerics' current Total Liabilities is ₹166.5 Mil. Overall, Lasa Supergenerics has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lasa Supergenerics' Total Liabilities compare to ZTS and UTHR?
Lasa Supergenerics' Total Liabilities of ₹166.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lasa Supergenerics and its competitors. Lasa Supergenerics's current Total Liabilities is ₹166.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lasa Supergenerics stock overvalued right now?
Based on GuruFocus' analysis, Lasa Supergenerics (NSE:LASA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹4.33, compared to a current price of ₹7.30 — trading 68.6% above its estimated fair value. The current Total Liabilities is ₹166.5 Mil. Lasa Supergenerics' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lasa Supergenerics (NSE:LASA), the current Total Liabilities is ₹166.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.30 is trading 68.6% above its estimated GF Value™ of ₹4.33. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

  • Total Liabilities: ₹166.5 Mil
  • GF Value™: ₹4.33 vs. price of ₹7.30 (68.6% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lasa Supergenerics Business Description

Other Exchanges 540702:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
47GF Score

Get the complete analysis for NSE:LASA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.30
Price
₹4.33
GF Value